Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 23 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (6)
Early P 1 (1)
P 1 (7)
P 2 (2)
P 3 (1)

Trial Status

Not Yet Recruiting8
Recruiting7
Completed3
Unknown2
Active Not Recruiting2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT07548944RecruitingPrimary

Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance

NCT07341763Not ApplicableNot Yet RecruitingPrimary

Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment

NCT07126470Not ApplicableRecruiting

Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients

NCT06789445Phase 1Recruiting

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

NCT07282457Phase 1Not Yet RecruitingPrimary

Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection)

NCT07266584Not ApplicableRecruiting

Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration

NCT06627179Phase 2RecruitingPrimary

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

NCT07348588Phase 1Active Not RecruitingPrimary

Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases

NCT07341919Phase 1Active Not Recruiting

Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases

NCT07292987Not ApplicableRecruitingPrimary

Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital

NCT07311863Early Phase 1Not Yet RecruitingPrimary

UGX202 Injection in Patients With Advanced Retinitis Pigmentosa

NCT07298174Not Yet Recruiting

Wide Field OCTA in Ocular Diseases

NCT07290530Phase 3Not Yet RecruitingPrimary

24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

NCT07265895Not Yet Recruiting

Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations

NCT07088705Not ApplicableEnrolling By InvitationPrimary

Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa

NCT06787482Phase 1RecruitingPrimary

Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies

NCT06908161Not Yet RecruitingPrimary

Functional Assessments in Vision Impairment

NCT06846151Not ApplicableNot Yet Recruiting

Retinal Investigation Using Optos OCT Device

NCT03975543UnknownPrimary

Retrospective Natural History Study of Retinitis Pigmentosa

NCT04763369Phase 2UnknownPrimary

Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP)

Scroll to load more

Research Network

Activity Timeline